Nonalcoholic fatty liver disease (NAFLD) is closely correlated with insulin resistance and
several metabolic syndrome features, but whether it could increase the risk of cardiovascular …

Nonalcoholic fatty liver disease (NAFLD) is increasingly recognized as an important
cardiovascular risk (CVR) factor. This is a narrative clinical review aimed at answering how …

NAFLD is very common in the general population and its prevalence is increasing
worldwide in parallel with the increasing incidences of obesity and metabolic diseases …

Background/objectives Recent studies have suggested an association between
nonalcoholic fatty liver disease (NAFLD) and diastolic cardiac dysfunction, although the …

The top three leading causes of death in patients with nonalcoholic fatty liver disease
(NAFLD) in descending order are cardiovascular disease, cancer, and liver disease. It is …

Nonalcoholic fatty liver disease (NAFLD), the most common of chronic liver disease in
Western Country, is closely related to insulin resistance and oxidative stress and includes a …

Nonalcoholic fatty liver disease (NAFLD) is a chronic condition characterized by fat
accumulation combined with low‐grade inflammation in the liver. A large body of clinical and …

Background Evidence suggests that nonalcoholic fatty liver disease (NAFLD) is associated
with cardiovascular diseases (CVDs). However, the results are inconsistent, and the …

The prevalence of non-alcoholic fatty liver disease (NAFLD) is strongly increasing and may
put patients at increased risk for atherosclerotic cardiovascular disease (asCVD). Both …

Background Nonalcoholic fatty liver disease (NAFLD) is increasingly prevalent and is
recognized as part of the metabolic syndrome (MetS). Patients with NAFLD have a lower life …